Related Experiment Videos

Foetal haemoglobin in Nigerian children with sickle cell anaemia. Effect on haematological parameters and clinical

O J Fatunde1, A B Scott-Emuakpor

  • 1Department of Child Health, University of Benin Teaching Hospital, Nigeria.

Tropical and Geographical Medicine
|July 1, 1992
PubMed

Insights

Higher fetal hemoglobin (HbF) levels in children with sickle cell anemia (SCA) correlate with fewer transfusions and hospitalizations. This study examined 86 children aged 5-16 years.

Area of Science:

  • Hematology
  • Pediatrics
  • Genetics

Background:

  • Sickle cell anemia (SCA) is a genetic blood disorder.
  • Fetal hemoglobin (HbF) can ameliorate SCA symptoms.
  • Understanding HbF's role in SCA is crucial for treatment.

Purpose of the Study:

  • To examine the relationship between fetal hemoglobin (HbF) levels and clinical/hematological parameters in children with SCA.
  • To investigate the impact of HbF on disease severity and physical development.

Main Methods:

  • Studied 86 children aged 5-16 years with SCA.
  • Measured HbF levels and correlated them with clinical data.
  • Analyzed associations with blood transfusions, hospital admissions, and physical development.

Main Results:

  • Mean HbF level was 6.8 +/- 3.6%.
  • Higher HbF levels significantly correlated with fewer blood transfusions and hospital admissions.
  • Higher HbF levels were associated with increased hepatomegaly.
  • A trend towards better physical development and more normal hemograms was observed with higher HbF, but not statistically significant.

Conclusions:

  • Elevated HbF levels show a protective effect in pediatric SCA patients.
  • HbF may mitigate disease severity, reducing transfusion and hospitalization needs.
  • Further research into HbF-boosting therapies for SCA is warranted.

Related Concept Videos